387
Participants
Start Date
April 4, 2016
Primary Completion Date
April 20, 2017
Study Completion Date
May 28, 2021
Nivolumab 3 mg/kg IV
Followed by Nivolumab monotherapy
Ipilimumab 1 mg/kg IV
Followed by Nivolumab monotherapy
Nivolumab 1 mg/kg IV
Ipilimumab 3 mg/kg IV
Nivolumab 6 mg/kg IV
A dose of 240mg is identical to a dose of 3mg/kg, therefore 6mg/kg is approximately equal to \~ 480mg.
Local Institution, North Sydney
Local Institution - 0045, Waratah
Local Institution - 0065, Herlev
Local Institution, Melbourne
Local Institution, Greenslopes
Local Institution - 0064, Odense
Local Institution - 0063, Aarhus N
Hopital De La Timone, Marseille
Lehigh Valley Health Network, Allentown
Local Institution, San Sabastian Gipuzkoa
Local Institution - 0042, Milan
University Of Virginia Health System, Charlottesville
Local Institution - 0039, Bergamo
Local Institution, Madrid
Local Institution - 0027, Madrid
Levine Cancer Institute, Charlotte
Institut Claudius Regaud, Toulouse
Hopital Saint Andre, Bordeaux
H. Lee Moffitt Cancer Center, Tampa
Istituto Oncologico Veneto IOV, Padua
Hopital Hotel Dieu, Nantes
Universitaetsklinikum Essen, Essen
Local Institution, Valencia
Local Institution - 0041, Siena
Allina Health, Fridley
Chru De Lille, Lille
Washington University School Of Medicine, St Louis
Universitaetsklinikum Heidelberg, Heidelberg
Centre Hospitalier Lyon Sud, Pierre-Bénite
Universitaetsklinikum Tuebingen, Tübingen
Hopital Saint Louis, Paris
University Of Colorado Cancer Center, Aurora
Local Institution - 0040, Napoli
Ludwig-Maximilians-Universitaet, München
Comprehensive Cancer Centers of Nevada, Las Vegas
Local Institution - 0019, Villejuif
Ospedale San Vincenzo, Taormina
University of Washington - Seattle Cancer Care Alliance, Seattle
Local Institution, Moscow
Local Institution, Ramat Gan
Dartmouth-Hitchcock Medical Center, Lebanon
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Local Institution - 0007, Edmonton
Princess Margaret Cancer Centre, Toronto
CHU de Quebec - Universite Laval, Québec
Local Institution - 0052, Amsterdam
Local Institution, Amsterdam
University Medical Center Groningen (Umcg), Groningen
Uniwersyteckie Centrum Kliniczne Klinika Onkologii I Radiote, Gdansk
Klinika Nowotworow Ukladowych i Uogolnionych, Krakow
Klinika Nowotworow Tkanek Miekkich, Kosci i Czerniakow, Warsaw
Local Institution, Badalona-barcelona
Local Institution - 0024, Barcelona
Local Institution, Manchester
Local Institution, Oxford
Local Institution, Guildford
Local Institution, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY